Sofia, Bulgaria, October 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that for the month of September 2023, the Company realized an increase in sales of 24% compared to the same month of the previous year, incl. 56% increase in domestic sales and 5% increase in export sales.

For the nine months from the beginning of 2023, sales increased by a total of 15%, incl. a 1% increase in domestic sales and a 25% increase in export sales.

Sofia, Bulgaria, October 16, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) notifies that today the Company received a notification for significant shareholding from CUPF Alianz Bulgaria.  As a result of the conditional capital increase through exercising warrants from issue BG9200001212, CUPF Alianz Bulgaria passively lowers its shareholding below the treshold of 5% in the capital of "Sopharma" AD to 4.09%.

Sofia, Bulgaria, October 16, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) notifies that in fulfillment of the goals for optimization of the foreign markets activities, the functions of the representative office of "Sopharma" AD in Russia will be taken over by the newly established subsidiary "Sopharma Rus" EOOD.

Sofia, Bulgaria, October 13, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for significant shareholding from “Telecomplect Invest” AD, UIC 201653294.  As a result of the conditional capital increase through exercising warrants from issue BG9200001212, “Telecomplect Invest” AD passively lowers its shareholding below the treshold of 20% in the capital of "Sopharma" AD to 16.155%.